What Are the Challenges Facing Biotechnology and Precision Medicine in Cancer?
Despite the advancements, several challenges remain. One major challenge is the high cost and complexity of genomic testing and biotechnology treatments. Additionally, the vast genetic diversity of tumors and the development of resistance to targeted therapies pose significant hurdles. Another challenge is ensuring equitable access to these cutting-edge treatments across different populations. Ongoing research and policy efforts aim to overcome these barriers and make precision medicine more accessible.